Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab.

about

Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia.

P2860

Q47870235-EE97B0DE-9646-4DE0-B388-D601BC429808

P2860

Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab.

Item

http://www.wikidata.org/entity/Q41149154

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Immunotargeting relapsed or re ...... ukemia - role of blinatumomab.

@en

type

Item

label

Immunotargeting relapsed or re ...... ukemia - role of blinatumomab.

@en

prefLabel

Immunotargeting relapsed or re ...... ukemia - role of blinatumomab.

@en

P1476

Immunotargeting relapsed or re ...... eukemia - role of blinatumomab

@en

P2093

Manon Queudeville

http://www.w3.org/2001/XMLSchema#string

Rupert Handgretinger

http://www.w3.org/2001/XMLSchema#string

P2860

EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine

Bispecific antibodies and their applications

Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia

Recent advancements of bortezomib in acute lymphocytic leukemia treatment

An antibody-deficiency syndrome due to mutations in the CD19 gene

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data.

Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells.

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.

Ordering human CD34+CD10-CD19+ pre/pro-B-cell and CD19- common lymphoid progenitor stages in two pro-B-cell development pathways.

P304

3567-3578

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S103470

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Ebinger

P577

2017-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28790849

http://www.w3.org/2001/XMLSchema#string

P932

5530848

http://www.w3.org/2001/XMLSchema#string

Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab.

about

P2860

P2860

Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P932